| Synonyms: | |
| Status: | Approved (1986) |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| ATC: | L04AA02 |
| UNII: | JGA39ICE2V |
Pharmacology
| Primary Target | |
|---|---|
| CD3e |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Melanoma | 2 | D008545 | ClinicalTrials |
| Kidney Neoplasms | 2 | D007680 | ClinicalTrials |
| Kidney Neoplasms | 2 | D007680 | ClinicalTrials |
| Non-alcoholic Fatty Liver Disease | 2 | D065626 | ClinicalTrials |
| Central Nervous System Neoplasms | 2 | D016543 | ClinicalTrials |
| Melanoma | 2 | D008545 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Colitis, Ulcerative | 1 | D003093 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 140608-64-6 |
| ChEMBL | CHEMBL1201608 |
| FDA SRS | JGA39ICE2V |
| Guide to Pharmacology | 6889 |
CONTENTS